SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-576683
Filing Date
2016-05-04
Accepted
2016-05-04 11:12:09
Documents
85
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d173578d10q.htm 10-Q 475592
2 EX-10.1 d173578dex101.htm EX-10.1 35675
3 EX-10.2 d173578dex102.htm EX-10.2 31260
4 EX-10.3 d173578dex103.htm EX-10.3 31696
5 EX-10.4 d173578dex104.htm EX-10.4 10571
6 EX-31.1 d173578dex311.htm EX-31.1 8434
7 EX-31.2 d173578dex312.htm EX-31.2 8670
8 EX-32.1 d173578dex321.htm EX-32.1 3985
  Complete submission text file 0001193125-16-576683.txt   3891301

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT mygn-20160331.xml EX-101.INS 772685
10 XBRL TAXONOMY EXTENSION SCHEMA mygn-20160331.xsd EX-101.SCH 47483
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20160331_cal.xml EX-101.CAL 87066
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20160331_def.xml EX-101.DEF 121906
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20160331_lab.xml EX-101.LAB 347300
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20160331_pre.xml EX-101.PRE 257220
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 161617998
SIC: 2835 In Vitro & In Vivo Diagnostic Substances